BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Z, Albanese J, Kesterson J, Warrick J, Karabakhtsian R, Dadachova E, Phaëton R. Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer. Transl Oncol 2019;12:1289-95. [PMID: 31325765 DOI: 10.1016/j.tranon.2019.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Barillari G, Bei R, Manzari V, Modesti A. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events? Int J Mol Sci 2021;22:13543. [PMID: 34948338 DOI: 10.3390/ijms222413543] [Reference Citation Analysis]
2 De Nola R, Loizzi V, Cicinelli E, Cormio G. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications. Crit Rev Oncol Hematol 2021;162:103343. [PMID: 33930531 DOI: 10.1016/j.critrevonc.2021.103343] [Reference Citation Analysis]
3 Donà MG, Di Bonito P, Chiantore MV, Amici C, Accardi L. Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies. Int J Mol Sci 2021;22:9143. [PMID: 34502053 DOI: 10.3390/ijms22179143] [Reference Citation Analysis]
4 Dong Z, Hu R, Du Y, Tan L, Li L, Du J, Bai L, Ma Y, Cui H. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Front Immunol 2020;11:586796. [PMID: 33488587 DOI: 10.3389/fimmu.2020.586796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sugumaran A, Mathialagan V. Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer. Curr Pharm Des 2020;26:5174-87. [PMID: 32586249 DOI: 10.2174/1381612826666200625110950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhu J, Kamara S, Wang Q, Guo Y, Li Q, Wang L, Chen J, Du Q, Du W, Chen S, Zhu S, Chen J, Chu M, Zhang L. Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells. Front Cell Dev Biol 2021;9:677867. [PMID: 34109181 DOI: 10.3389/fcell.2021.677867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Paolini F, Amici C, Carosi M, Bonomo C, Di Bonito P, Venuti A, Accardi L. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors. J Exp Clin Cancer Res 2021;40:37. [PMID: 33485370 DOI: 10.1186/s13046-021-01841-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]